Gareth Pryce
- Pharmacology top 0.1%
- Cannabis and Cannabinoid Research 35
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms 17
-
- Neuroscience and Neuropharmacology Research 17
- Pathology and Forensic Medicine top 0.5%
- Multiple Sclerosis Research Studies 31
- Biological Psychiatry top 2%
-
- T-cell and B-cell Immunology 17
- Immunotherapy and Immune Responses 12
- Immune Response and Inflammation 9
-
- Monoclonal and Polyclonal Antibodies Research 16
- Co-authors
- David BakerGavin GiovannoniDavid MaleJ. Ludovic CroxfordVincenzo Di MarzoRoger G. PertweeKlaus SchmiererPeter Brown
- Journals
- Journal of Neuroimmunology (11 papers)Multiple Sclerosis and Related Disorders (8 papers)The FASEB Journal (5 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Gareth Pryce
103 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 113
- Pharmacology 2.9k
- Neurology 840
- Cellular and Molecular Neuroscience 1.8k
- Pathology and Forensic Medicine 1.4k
- Biological Psychiatry 188
Countries citing papers authored by Gareth Pryce
This map shows the geographic impact of Gareth Pryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gareth Pryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gareth Pryce more than expected).
Fields of papers citing papers by Gareth Pryce
This network shows the impact of papers produced by Gareth Pryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gareth Pryce. The network helps show where Gareth Pryce may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gareth Pryce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 91 | |
| 2 | 2018 | 37 | |
| 3 | 2017 | 15 | |
| 4 | 2013 | 9 | |
| 5 | 2013 | 25 | |
| 6 | Selective targeting of neuroprotection to MS lesions: sodium channel blockers in experimental autoimmune encephalomyelitis | 2011 | 1 |
| 7 | 2011 | 18 | |
| 8 | 2008 | 54 | |
| 9 | 2007 | 20 | |
| 10 | 2005 | 59 | |
| 11 | 2005 | 60 | |
| 12 | 2005 | 69 | |
| 13 | 2003 | 83 | |
| 14 | 2003 | 276 | |
| 15 | 2003 | 36 | |
| 16 | 2002 | 96 | |
| 17 | 2002 | 68 | |
| 18 | 2000 | 428 | |
| 19 | 2000 | 20 | |
| 20 | 1988 | 33 |
About Gareth Pryce
Gareth Pryce is a scholar working on Neurology, Immunology, Pharmacology, Pathology and Forensic Medicine and Immunology and Allergy, having authored 104 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (35 papers), Multiple Sclerosis Research Studies (31 papers), Neuroinflammation and Neurodegeneration Mechanisms (17 papers), Neuroscience and Neuropharmacology Research (17 papers), T-cell and B-cell Immunology (17 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Immunotherapy and Immune Responses (12 papers) and Immune Response and Inflammation (9 papers). The work is most often cited by research in Pharmacology (2.9k citations), Neurology (840 citations), Cellular and Molecular Neuroscience (1.8k citations), Pathology and Forensic Medicine (1.4k citations) and Biological Psychiatry (188 citations). Gareth Pryce has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include David Baker, Gavin Giovannoni, David Male, J. Ludovic Croxford, Vincenzo Di Marzo, Roger G. Pertwee, Klaus Schmierer, Peter Brown, Samuel J. Jackson and Alan J. Thompson. Their work appears in journals such as Journal of Neuroimmunology, Multiple Sclerosis and Related Disorders, The FASEB Journal, British Journal of Pharmacology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.